ADVANCED OVARIAN CANCER
Clinical trials for ADVANCED OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OVARIAN CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail aims to stall ovarian cancer
Disease control OngoingThis Phase 3 trial tests whether adding durvalumab (an immunotherapy) and olaparib (a targeted drug) to standard chemotherapy and bevacizumab can help people with newly diagnosed advanced ovarian cancer live longer without their cancer growing. About 1,400 participants are involv…
Matched conditions: ADVANCED OVARIAN CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New pill could keep ovarian cancer at bay for BRCA patients
Disease control OngoingThis phase 3 trial tests whether taking olaparib tablets daily can delay the return of advanced ovarian cancer in women with BRCA gene mutations. Participants had already responded to initial platinum chemotherapy. The study compares olaparib to a placebo over up to two years, me…
Matched conditions: ADVANCED OVARIAN CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Prehabilitation may cut surgery risks in ovarian cancer
Symptom relief OngoingThis study looks at whether a program called prehabilitation—which helps patients get stronger and healthier before surgery—can lower the chance of problems after surgery for advanced ovarian cancer. About 146 women having surgery for ovarian cancer will take part. The goal is to…
Matched conditions: ADVANCED OVARIAN CANCER
Phase: NA • Sponsor: Hospital Clinic of Barcelona • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
AI could help ovarian cancer patients get surgery at the right time
Knowledge-focused OngoingThis study uses artificial intelligence to analyze data from over 1,000 people with advanced ovarian cancer. The goal is to create a tool that helps doctors decide whether to perform surgery right away or after chemotherapy. The research combines information from a previous clini…
Matched conditions: ADVANCED OVARIAN CANCER
Sponsor: Shanghai Gynecologic Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC